BMC Infectious Diseases

official impact factor 2.83
Search for
Advanced search
BMC Infectious Diseases
Tools
Share this article
Open Access Email this article to a friend

Hepatic profile analyses of tipranavir in Phase II and III clinical trials

Jaromir Mikl*, Mark S Sulkowski, Yves Benhamou, Douglas Dieterich, Stanislas Pol, Jürgen Rockstroh, Patrick A Robinson, Mithun Ranga and Jerry O Stern

BMC Infectious Diseases 2009, 9:203 doi:10.1186/1471-2334-9-203

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.